Lee Sangil, Hess Erik P, Lohse Christine, Souza Dante Lucas S, Campbell Ronna L
Department of Emergency Medicine, Mayo Clinic Health System, Mankato, Minn.
Department of Emergency Medicine, Mayo Clinic, Rochester, Minn.
J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1182-1186.e1. doi: 10.1016/j.jaip.2016.05.006. Epub 2016 Jun 7.
The prescribing pattern of epinephrine over time is an indicator of the secular trend of anaphylaxis. However, it is not well known in a population level in the United States.
To evaluate the trend of prescriptions for epinephrine autoinjectors in Olmsted County, Minn, residents.
Outpatient prescriptions for epinephrine were identified among residents of Olmsted County, Minn, between January 1, 2004, and December 31, 2010. We used the first prescription per patient per year, and the first prescription per patient during the study period to calculate incidence rates. Incidence rates per 100,000 person-years were calculated using patients prescribed epinephrine per year as the numerator and age- and sex-specific counts of the population of Olmsted County as the denominator. The relationships of age group, sex, and year of prescription with incidence rates were assessed by fitting Poisson regression models using the SAS procedure GENMOD.
The overall incidence rate of epinephrine autoinjector prescriptions during the study period was 757 per 100,000 person-years (95% confidence interval: 740-774). The prescription rates per patient per year increased over time, with an annual rate of increase of 8% (P < .001), but the rates per patient remained stable (P = .077). For each year, incidence rates overall were higher in women compared with men (P < .001). From ages 0 to 19, incidence rates were higher in boys compared with girls. At age 20 and above, incidence rates were higher in women compared with men.
The overall rate of epinephrine autoinjector prescriptions increased, but the rate of first-time prescriptions was stable from 2005 to 2010. In childhood, boys were more likely to receive a prescription than girls, but this reversed in later ages.
随着时间推移,肾上腺素的处方模式是过敏反应长期趋势的一个指标。然而,在美国的人群层面上,这一情况并不为人所知。
评估明尼苏达州奥尔姆斯特德县居民中肾上腺素自动注射器的处方趋势。
在2004年1月1日至2010年12月31日期间,确定明尼苏达州奥尔姆斯特德县居民的肾上腺素门诊处方。我们采用每位患者每年的第一张处方以及研究期间每位患者的第一张处方来计算发病率。每10万人年的发病率以每年开具肾上腺素处方的患者数为分子,以奥尔姆斯特德县按年龄和性别划分的人口数为分母进行计算。通过使用SAS程序GENMOD拟合泊松回归模型,评估年龄组、性别和处方年份与发病率之间的关系。
研究期间,肾上腺素自动注射器处方的总体发病率为每10万人年757例(95%置信区间:740 - 774)。每年每位患者的处方率随时间增加,年增长率为8%(P <.001),但每位患者的处方率保持稳定(P =.077)。每年,女性的总体发病率高于男性(P <.001)。在0至19岁年龄段,男孩的发病率高于女孩。在20岁及以上年龄段,女性的发病率高于男性。
肾上腺素自动注射器处方的总体比率有所增加,但2005年至2010年首次处方率保持稳定。在儿童时期,男孩比女孩更有可能获得处方,但在 later ages(此处原文有误,推测可能是“later ages”,应改为“later ages”,即“更高年龄段”)情况则相反。